Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer.
Saved in:
| Title: | Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer. |
|---|---|
| Authors: | Ross A; Northwestern Feinberg School of Medicine, Chicago, IL, USA., Brewer K; Clinical Outcomes Solutions, Chicago, IL, USA., Hudgens S; Clinical Outcomes Solutions, Tucson, AZ, USA., Brown B; Myovant Sciences Inc, Brisbane, CA, USA., Fallick M; Myovant Sciences Inc, Brisbane, CA, USA., de Paauw-Holt S; Sumitomo Pharma Switzerland GmbH, Aeschengraben 27, 4051, Basel, Switzerland., Arondekar B; Pfizer, Inc, Collegeville, PA, USA., Clegg J; Clinical Outcomes Solutions, Chicago, IL, USA., Hunsche E; Sumitomo Pharma Switzerland GmbH, Aeschengraben 27, 4051, Basel, Switzerland. elke.hunsche@ch.sumitomo-pharma.com. |
| Source: | Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3076-3088. Date of Electronic Publication: 2024 Jun 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-024-02888-9 |
